Home›Stock Screener›J B Chemicals and Pharmaceuticals

J B Chemicals and Pharmaceuticals Share Price Today | Stock Price & J B Chemicals and Pharmaceuticals Share Screener

JBCHEPHARM Pharmaceuticals
Live Share Price NSE
₹2506.00
▲ 18.40 (0.74%)
2026-07-15 00:00:00
Live Share Price BSE
₹2505.60
▲ 18.75 (0.75%)
2026-07-15 00:00:00

As of July 15, 2026, the live J B Chemicals and Pharmaceuticals share price (NSE: JBCHEPHARM) is ₹2,506.00 on NSE and ₹2,505.60 on BSE, up 0.74% from the previous close, with shares trading between ₹2,441.30 and ₹2,510.00 in today's trading session, and a 52-week range of ₹1,729.60–₹2,506.00. Track JBCHEPHARM market value to gauge the company's total market size. Use the J B Chemicals and Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today J B Chemicals and Pharmaceuticals opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹916 and net income of ₹101, with EBITDA of ₹186, an operating margin of 19.0% and a profit margin of 11.0%.

J B Chemicals and Pharmaceuticals Market Cap ₹40,236.01 Cr.
JBCHEPHARM P/E Ratio (TTM) 56.28
J B Chemicals and Pharmaceuticals P/B Ratio 9.60
EPS (TTM) ₹45.16
Dividend Yield 0.88%
Debt to Equity -
JBCHEPHARM 52 Week High ₹2506.00
J B Chemicals and Pharmaceuticals 52 Week Low ₹1729.60
Operating Margin 19.00%
Profit Margin 11.03%
JBCHEPHARM Revenue (TTM) ₹916.00
EBITDA ₹186.00
Net Income ₹101.00
Total Assets ₹4,969.00
Total Equity ₹4,159.00

J B Chemicals and Pharmaceuticals Share Price Chart

Track the current stock price of J B Chemicals and Pharmaceuticals with an interactive chart. Analyse JBCHEPHARM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete J B Chemicals and Pharmaceuticals stock quote in one place.

The quote of ₹2,506.00 sits between the 52-week low of ₹1,729.60 and the 52-week high of ₹2,506.00, and the latest session moved 0.74% from the previous close.

J B Chemicals and Pharmaceuticals Company Profile - Fundamental Screener

Screen J B Chemicals and Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JBCHEPHARM shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, with Arun Duggal listed as chairperson or CEO, and it trades under ISIN INE572A01036.

Business Overview

J.B. Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1976. It manufactures and markets a range of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. The company specializes in gastroenterology, hypertension, and dermatology, with additional focus on nephrology, respiratory, virology, diabetes, and nicotine replacement therapy. Key brands...more

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

Chairperson/CEO Arun Duggal
ISIN INE572A01036

J B Chemicals and Pharmaceuticals Balance Sheet Screener

Screen JBCHEPHARM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹4,969, up from ₹4,274 in 2025.

Latest statistics put total assets at ₹4,969 and shareholder funds at ₹4,159.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 4,969 4,274 3,994 3,554 2,607 2,238 1,821 1,792 1,765 1,674
Current Assets 2,909 1,923 1,853 1,528 1,253 1,553 1,073 1,051 1,047 795
Fixed Assets 1,885 1,968 2,004 1,901 1,277 634 651 621 640 679

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 218 208 203 519 85 79 69 65 46 27
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 4,159 3,433 2,923 2,480 2,139 1,813 1,438 1,483 1,444 1,366
Share Capital 16 16 16 16 16 16 16 16 17 17
Reserves & Surplus 4,143 3,418 2,908 2,465 2,119 1,794 1,420 1,464 1,425 1,347

J B Chemicals and Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis

Screen J B Chemicals and Pharmaceuticals income statement and profit fundamentals. Analyze JBCHEPHARM quarterly results. J B Chemicals and Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹916 and net profit was ₹101, equal to earnings per unit of ₹6.35, at an operating margin of 19%.

In that period expenses were ₹730, interest cost ₹1 and tax ₹33. The next period listed, 2025-Dec, shows revenue of ₹1,083 and net profit of ₹198.

Item 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec 2022-Sept

Revenue and Expenses

Revenue 916 1,083 1,100 1,109 964 972 1,011 1,010 878 852 889 902 767 796 811
Expenses 730 769 775 793 723 709 730 724 664 621 638 664 599 618 625

Operating Costs and Margins

EBITDA 186 314 325 315 241 263 281 286 215 231 251 238 168 178 186
Operating Profit % 19.00% 28.00% 29.00% 28.00% 24.00% 26.00% 27.00% 28.00% 23.00% 26.00% 28.00% 26.00% 21.00% 22.00% 23.00%
Depreciation 50 45 44 43 46 42 42 41 41 34 32 31 32 28 28
Interest 1 2 1 1 2 3 2 6 9 13 10 12 14 8 8

Profit and Earnings

Profit Before Tax 135 267 279 272 193 218 237 240 165 184 209 194 123 141 150
Tax 33 69 71 69 47 56 62 63 38 50 58 52 35 35 39
Net Profit 101 198 208 202 146 163 175 177 126 134 151 142 88 106 111
EPS 6.35 12.63 13.29 12.99 9.36 10.46 11.24 11.39 8.22 8.62 9.72 9.20 11.33 13.72 14.37

J B Chemicals and Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals

Screen JBCHEPHARM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹704, and net cash flow was an outflow of ₹5.

Over the same period, investing activities used ₹586 and financing activities used ₹123.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 704 903 801 626 170 315 276 194 123 201
Investing Activities -586 -296 -404 -962 2 -231 24 -28 -21 -45

Financing and Net Cash

Financing Activities -123 -580 -386 357 -138 -87 -306 -156 -60 -184
Net Cash Flow -5 27 11 20 34 -3 -6 11 43 -28

J B Chemicals and Pharmaceuticals Shareholding Pattern Screener

See J B Chemicals and Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check J B Chemicals and Pharmaceuticals promoter holding and ownership changes for JBCHEPHARM on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 48.80%, foreign institutions 16.33%, domestic institutions 21.38% and the public 11.77%, spread across 74,043 shareholders.

The shareholder count was 74,043 in 2026-Mar, compared with 68,966 in 2026-Jan.

Item 2026-Mar 2026-Jan 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 48.80% 48.78% 47.84% 47.73% 47.56% 47.55% 53.78% 53.77%

Institutional Investors

FII Holding 16.33% 14.56% 18.30% 17.77% 15.30% 14.88% 11.06% 12.17%
DII Holding 21.38% 22.71% 18.72% 19.63% 22.83% 23.36% 18.38% 17.62%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.00%
Public Holding 11.77% 12.03% 13.28% 13.04% 12.47% 12.37% 14.69% 14.38%
Other Holding 1.71% 1.92% 1.86% 1.83% 1.84% 1.85% 2.09% 2.05%
Shareholder Count 74,043 68,966 63,948 70,064 71,957 69,338 63,892 66,953

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by J B Chemicals and Pharmaceuticals. J B Chemicals and Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹22.00 per unit for 2026-March, a yield of 0.88%, compared with ₹15.50 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹22.00, ₹15.50 and ₹12.25 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹22.00 0.88%
2025-March ₹15.50 0.75%
2024-March ₹12.25 0.75%
2023-March ₹17.75 1.08%
2022-March ₹16.50 1.67%
2021-March ₹16.50 2.10%
2020-March ₹11.00 1.75%
2019-March ₹5.00 1.96%
2018-March ₹2.00 1.10%
2017-March ₹1.00 0.64%

J B Chemicals and Pharmaceuticals Stock Index Membership - Nifty & Sensex

See which indices include J B Chemicals and Pharmaceuticals stock. Check JBCHEPHARM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 20 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
BSE INDEX SMLSEL
NIFTY 500
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY MNC
NIFTY MULTI MFG
NIFTY PHARMA
NIFTY SMALLCAP250 QUALITY 50
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH

J B Chemicals and Pharmaceuticals Market Events Screener - Corporate Actions

Get J B Chemicals and Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check J B Chemicals and Pharmaceuticals stock events that may affect JBCHEPHARM share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Merger - Demerger dated July 17, 2026, with a record date of July 17, 2026.

It is followed by Annual General Meeting dated June 17, 2026 and Dividend dated May 29, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-07-17 2026-07-17 Merger - Demerger 100:51 0.00%
2026-06-17 2026-06-17 Annual General Meeting NA 0.01%
2026-05-29 2026-05-29 Dividend ₹ 9.30 /share 2.44%
2026-05-11 2026-05-11 Quarterly Result Announcement NA 3.25%
2026-04-28 2026-04-28 Extraordinary General Meeting NA -1.68%
2026-02-11 2026-02-11 Dividend ₹ 12.70 /share 1.60%
2026-01-16 2026-01-16 Quarterly Result Announcement NA 4.16%
2025-11-11 2025-11-11 Quarterly Result Announcement NA 6.12%
2025-08-06 2025-08-06 Annual General Meeting NA 4.95%
2025-07-30 2025-07-30 Quarterly Result Announcement NA 9.13%
2025-07-30 2025-07-30 Dividend ₹ 7.00 /share 14.10%
2025-05-14 2025-05-14 Quarterly Result Announcement NA -4.75%
2025-02-07 2025-02-08 Dividend ₹ 8.50 /share -2.35%
2025-02-04 2025-02-04 Quarterly Result Announcement NA -5.04%
2024-11-06 2024-11-06 Quarterly Result Announcement NA -2.31%

J B Chemicals and Pharmaceuticals Competitors Screener - Peer Stocks Comparison

Screen JBCHEPHARM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 468,230 40.45 61,674 12.69% 11,565 69.50
Divis Laboratories 193,075 74.28 10,560 8.73% 2,520 73.34
Torrent Pharmaceuticals 169,825 78.68 13,886 20.34% 2,138 80.61
Zydus Life Science 116,411 22.08 27,658 17.64% 5,026 64.38
Cipla 116,168 30.10 29,045 2.24% 3,870 55.25
Lupin 113,988 21.08 27,488 19.98% 5,345 65.40
Mankind Pharma 105,029 53.92 14,278 12.03% 1,750 59.45
Dr Reddys Laboratories 102,623 25.01 35,059 3.90% 4,158 34.68
Aurobindo Pharma 89,195 25.75 33,385 3.21% 3,376 54.09
Laurus Labs 83,910 94.65 6,868 22.01% 890 65.68

J B Chemicals and Pharmaceuticals Company Announcements - News & Reports Screener

Screen JBCHEPHARM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 13, 2026.

The next most recent announcements are dated November 12, 2026 and November 12, 2026.

Date Update Actions
2026-11-13 Intimation Of Effective Date Of Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders -
2026-11-12 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-11-12 Record Date For The Purpose Of Determining The Shareholders Of The Company Who Shall Be Entitled To Receive Fully Paid-Up Equity Shares Of Torrent Pharma As Per The Share Exchange Ratio -
2026-11-12 Receipt Of Certified Copy Of Order Passed By National Company Law Tribunal Ahmedabad Bench (NCLT) Regarding The Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders. -
2026-11-11 Pronouncement Of Final Order By The HonBle National Company Law Tribunal Ahmedabad Bench Sanctioning The Scheme Of Amalgamation Of J. B. Chemicals & Pharmaceuticals Limited With Torrent Pharmaceuticals Limited And Their Respective Shareholders -
2026-06-30 Closure of Trading Window -
2026-06-30 Announcement under Regulation 30 (LODR)-Change in Management -
2026-06-17 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-06-17 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-06-15 Announcement under Regulation 30 (LODR)-Change in Management -
2026-06-12 Announcement under Regulation 30 (LODR)-Change in Management -
2026-05-27 Letter To Shareholders - Integrated Annual Report 2025-26 -
2026-05-26 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-25 Business Responsibility and Sustainability Reporting (BRSR) -
2026-05-25 Reg. 34 (1) Annual Report. -
2026-05-25 Intimation Of Notice Of AGM To Be Held On June 17 2026 -
2026-05-22 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-21 Intimation Of Record Date -
2026-05-20 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-13 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹2,506.00, within a 52-week range of ₹1,729.60 to ₹2,506.00. The P/E ratio is 56.28 and the P/B ratio is 9.60, with earnings per unit of ₹45.16. Market capitalisation stands at ₹40,236.01 Cr and the dividend yield is 0.88%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.